ROLIMUS 5 TABLETS

Form: Tablet

Pack Size: 10 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹8877.92

Rolimus 5mg by Cipla (everolimus 5 mg, 10 tablets) is an mTOR inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for advanced hormone receptor-positive breast cancer (with exemestane), advanced kidney cancer, neuroendocrine tumours and tumours linked to tuberous sclerosis complex. Schedule H: dispense only against a valid prescription. Counselling point: mouth ulcers are common; new cough or breathlessness needs review (possible pneumonitis).

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.